Catheter-based renal sympathetic denervation for the treatment of resistant arterial hypertension in Poland - Experts consensus statement;Stanowisko grupy ekspertów w sprawie zabiegów przezskórnej denerwacji nerek w leczeniu nadciśnienia tȩtniczego w Polsce

Kardiologia Polska

Volumn 69, Issue 11, 2011, Pages 1208-1211

  Witkowski, Adam ^a   Januszewicz, Andrzej ^a   Imiela, Jacek ^b   Narkiewicz, Krzysztof ^c   Opolski, Grzegorz ^d   Rowiński, Olgierd ^e   Sadowski, Jerzy ^f   Dudek, Dariusz ^f   Bryniarski, Leszek ^f   Gil, Robert J ^g   Adamczak, Marcin ^h   Grajek, Stefan ⁱ   Ka̧dziela, Jacek ^a   Prejbisz, Aleksander ^a   Nowicki, Maciej ^j  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b Miedzyleski Szpital Specjalistyczny w Warszawa   (Poland)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d WARSZAWSKI UNIWERSYTET MEDYCZNY   (Poland)

^e MEDICAL UNIVERSITY OF WARSAW   (Poland)

^f JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^g CENTRAL CLINICAL HOSPITAL OF THE MINISTRY OF INTERIOR   (Poland)

^h MEDICAL UNIVERSITY OF SILESIA   (Poland)

ⁱ POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^j HTA Audit   (Poland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; HYPERTENSION; KIDNEY DENERVATION; URINARY CATHETER;

EID: 81555222774     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Mancia G, De Backer G, Dominiczak A et al. 2007 Guidelines for the Management of Arterial Hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens, 2007; 25: 1105-1187. (Pubitemid 46924065)
2. Mancia G, Laurent S, Agabiti-Rosei E et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens, 2009; 27: 2121-2158.
3. Calhoun DA, Jones D, Textor S et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension, 2008; 51: 1403-1419.
4. Januszewicz A, Prejbisz A. Oporne nadciśnienie tȩtnicze. Zasady postȩpowania w praktyce lekarskiej. Via Medica, Gdańsk 2009.
5. Krum H, Schlaich M, Whitbourn R et al. Catheter-based renal sympathetic denervation for resistant hyertension: a multicentre safety and-proof-of- principle cohort study. Lancet, 2009; 373: 1275-1281.
6. Esler MD, Krum H, Sobotka PA et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The- Symplicity HTN-2 Trial): a randomised controlled trial. Lancet, 2010; 376:1903-1909.
7. Schlaich MP, Sobotka PA, Krum H et al. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med, 2009; 361: 932-934.
8. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension durability of blood pressure reduction out to 24 months. Hypertension, 2011; 57: 911-917.
9. Mahfoud F, Schlaich M, Kindermann I et al. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation, 2011; 123: 1940-1946.
10. Witkowski A, Prejbisz A, Florczak E et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course and glycemic control in patients with resistant hypertensios and sleep apnea. Hypertension, 2011; 58: 559-565.